MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 365 filers reported holding MEDIVATION INC in Q1 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,826,000 | -46.5% | 114,726 | -0.2% | 0.12% | -33.9% |
| Q1 2016 | $5,283,000 | -21.9% | 114,902 | -17.9% | 0.18% | -16.3% |
| Q4 2015 | $6,768,000 | -80.1% | 140,000 | -82.5% | 0.22% | -71.4% |
| Q3 2015 | $34,000,000 | -25.6% | 800,000 | +100.0% | 0.75% | -17.1% |
| Q2 2015 | $45,680,000 | -11.5% | 400,000 | 0.0% | 0.91% | -13.8% |
| Q1 2015 | $51,628,000 | +29.6% | 400,000 | 0.0% | 1.05% | +27.0% |
| Q4 2014 | $39,845,000 | +0.7% | 400,000 | 0.0% | 0.83% | -8.0% |
| Q3 2014 | $39,549,000 | +28.3% | 400,000 | 0.0% | 0.90% | +30.4% |
| Q2 2014 | $30,832,000 | +19.7% | 400,000 | 0.0% | 0.69% | +23.8% |
| Q1 2014 | $25,749,000 | +0.9% | 400,000 | 0.0% | 0.56% | -1.2% |
| Q4 2013 | $25,528,000 | +6.5% | 400,000 | 0.0% | 0.56% | -2.4% |
| Q3 2013 | $23,976,000 | +21.8% | 400,000 | 0.0% | 0.58% | +13.3% |
| Q2 2013 | $19,680,000 | – | 400,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |